MuntnerP, ShimboD, CareyRM, CharlestonJB, GaillardT, MisraS, et al..: Measurement of blood pressure in humans: A scientific statement from the American Heart Association. Hypertension73: e35–e66, 2019PubMed
MuntnerP, ShimboD, CareyRM, CharlestonJB, GaillardT, MisraS, .: Measurement of blood pressure in humans: A scientific statement from the American Heart Association. Hypertension73: e35–e66, 2019PubMed10.1161/HYP.0000000000000087)| false
WheltonPK, CareyRM, AronowWS, CaseyDEJr, CollinsKJ, Dennison HimmelfarbC, et al..: 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension71: e13–e115, 2018PubMed
WheltonPK, CareyRM, AronowWS, CaseyDEJr, CollinsKJ, Dennison HimmelfarbC, .: 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension71: e13–e115, 2018PubMed)| false
NerenbergKA, ZarnkeKB, LeungAA, DasguptaK, ButaliaS, McBrienK, et al..: Hypertension Canada: Hypertension Canada’s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children. can J Cardiol34: 506–525, 2018PubMed
RakotzMK, TownsendRR, YangJ, AlpertBS, HeneghanKA, WyniaM, et al..: Medical students and measuring blood pressure: Results from the American Medical Association blood pressure check challenge. J Clin Hypertens (Greenwich)19: 614–619, 2017PubMed
RakotzMK, TownsendRR, YangJ, AlpertBS, HeneghanKA, WyniaM, .: Medical students and measuring blood pressure: Results from the American Medical Association blood pressure check challenge. J Clin Hypertens (Greenwich)19: 614–619, 2017PubMed10.1111/jch.13018)| false
KallioinenN, HillA, HorswillMS, WardHE, WatsonMO: Sources of inaccuracy in the measurement of adult patients’ resting blood pressure in clinical settings: A systematic review. J Hypertens35: 421–441, 2017PubMed
KallioinenN, HillA, HorswillMS, WardHE, WatsonMO: Sources of inaccuracy in the measurement of adult patients’ resting blood pressure in clinical settings: A systematic review. J Hypertens35: 421–441, 2017PubMed10.1097/HJH.0000000000001197)| false
American Heart Association and American Medical Association: Target: BP (Tools & Downloads). https://targetbp.org/tools-downloads/?sort=topic&topics=Patient-Measured%20BP&. Revised 25 Jul 2019. Accessed 28 Jul 2019)| false
Self-Measured Blood Pressure Monitoring: Actions Steps for Clinicians, Atlanta, GA, Centers for Disease Control and Prevention, US Dept of Health and Human Services, 2014
Self-Measured Blood Pressure Monitoring: Actions Steps for Clinicians, Atlanta, GA, Centers for Disease Control and Prevention, US Dept of Health and Human Services, 2014)| false
YarowsSA, QianK: Accuracy of aneroid sphygmomanometers in clinical usage: University of Michigan experience. Blood Press Monit6: 101–106, 2001PubMed10.1097/00126097-200104000-00006)| false
CohenJB, PadwalRS, GutkinM, GreenBB, BlochMJ, GerminoFW, et al..: History and justification of a national blood pressure measurement validated device listing. Hypertension73: 258–264, 2019PubMed
CohenJB, PadwalRS, GutkinM, GreenBB, BlochMJ, GerminoFW, .: History and justification of a national blood pressure measurement validated device listing. Hypertension73: 258–264, 2019PubMed10.1161/HYPERTENSIONAHA.118.11990)| false
SharmanJE, O’BrienE, AlpertB, SchutteAE, DellesC, Hecht OlsenM, et al..: Lancet Commission on Hypertension Group: Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure. J Hypertens38: 21–29, 2020PubMed
SharmanJE, O’BrienE, AlpertB, SchutteAE, DellesC, Hecht OlsenM, .: Lancet Commission on Hypertension Group: Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure. J Hypertens38: 21–29, 2020PubMed10.1097/HJH.0000000000002246)| false
KuwabaraM, HaradaK, HishikiY, KarioK: Validation of two watch-type wearable blood pressure monitors according to the ANSI/AAMI/ISO81060-2:2013 guidelines: Omron HEM-6410T-ZM and HEM-6410T-ZL. J Clin Hypertens (Greenwich)21: 853–858, 2019PubMed
KuwabaraM, HaradaK, HishikiY, KarioK: Validation of two watch-type wearable blood pressure monitors according to the ANSI/AAMI/ISO81060-2:2013 guidelines: Omron HEM-6410T-ZM and HEM-6410T-ZL. J Clin Hypertens (Greenwich)21: 853–858, 2019PubMed10.1111/jch.13499)| false
SaitoK, HishikiY, TakahashiH: Validation of two automatic devices, Omron HEM-6232T and HEM-6181, for self-measurement of blood pressure at the wrist according to the ANSI/AAMI/ISO 81060-2:2013 protocol and the European Society of Hypertension International Protocol revision 2010. Vasc Health Risk Manag15: 47–55, 2019PubMed
SaitoK, HishikiY, TakahashiH: Validation of two automatic devices, Omron HEM-6232T and HEM-6181, for self-measurement of blood pressure at the wrist according to the ANSI/AAMI/ISO 81060-2:2013 protocol and the European Society of Hypertension International Protocol revision 2010. Vasc Health Risk Manag15: 47–55, 2019PubMed10.2147/VHRM.S188089)| false
ChobanianAV, BakrisGL, BlackHR, CushmanWC, GreenLA, IzzoJLJr, et al..: National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA289: 2560–2572, 2003PubMed
ChobanianAV, BakrisGL, BlackHR, CushmanWC, GreenLA, IzzoJLJr, .: National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA289: 2560–2572, 2003PubMed10.1001/jama.289.19.2560)| false
RoereckeM, KaczorowskiJ, MyersMG: Comparing automated office blood pressure readings with other methods of blood pressure measurement for identifying patients with possible hypertension: A systematic review and meta-analysis. JAMA Intern Med179: 351–362, 2019PubMed
RoereckeM, KaczorowskiJ, MyersMG: Comparing automated office blood pressure readings with other methods of blood pressure measurement for identifying patients with possible hypertension: A systematic review and meta-analysis. JAMA Intern Med179: 351–362, 2019PubMed10.1001/jamainternmed.2018.6551)| false
PiperMA, EvansCV, BurdaBU, MargolisKL, O’ConnorE, WhitlockEP: Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: A systematic review for the U.S. Preventive Services Task Force. Ann Intern Med162: 192–204, 2015PubMed
PiperMA, EvansCV, BurdaBU, MargolisKL, O’ConnorE, WhitlockEP: Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: A systematic review for the U.S. Preventive Services Task Force. Ann Intern Med162: 192–204, 2015PubMed10.7326/M14-1539)| false
YangWY, MelgarejoJD, ThijsL, ZhangZY, BoggiaJ, WeiFF, et al..: International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes (IDACO) Investigators: Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes. JAMA322: 409–420, 2019PubMed
YangWY, MelgarejoJD, ThijsL, ZhangZY, BoggiaJ, WeiFF, .: International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes (IDACO) Investigators: Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes. JAMA322: 409–420, 2019PubMed10.1001/jama.2019.9811)| false
KronishIM, KentS, MoiseN, ShimboD, SaffordMM, KynerdRE, et al..: Barriers to conducting ambulatory and home blood pressure monitoring during hypertension screening in the United States. J Am Soc Hypertens11: 573–580, 2017PubMed
KronishIM, KentS, MoiseN, ShimboD, SaffordMM, KynerdRE, .: Barriers to conducting ambulatory and home blood pressure monitoring during hypertension screening in the United States. J Am Soc Hypertens11: 573–580, 2017PubMed10.1016/j.jash.2017.06.012)| false
DrawzPE, AlperAB, AndersonAH, BrecklinCS, CharlestonJ, ChenJ, et al..: Chronic Renal Insufficiency Cohort Study Investigators: Masked hypertension and elevated nighttime blood pressure in CKD: Prevalence and association with target organ damage. Clin J Am Soc Nephrol11: 642–652, 2016PubMed
DrawzPE, AlperAB, AndersonAH, BrecklinCS, CharlestonJ, ChenJ, .: Chronic Renal Insufficiency Cohort Study Investigators: Masked hypertension and elevated nighttime blood pressure in CKD: Prevalence and association with target organ damage. Clin J Am Soc Nephrol11: 642–652, 2016PubMed10.2215/CJN.08530815)| false
ScheppachJB, RaffU, ToncarS, RitterC, KlinkT, StörkS, et al..: Blood pressure pattern and target organ damage in patients with chronic kidney disease. Hypertension72: 929–936, 2018PubMed
KuE, HsuRK, TuotDS, BaeSR, LipkowitzMS, SmogorzewskiMJ, et al..: Magnitude of the difference between clinic and ambulatory blood pressures and risk of adverse outcomes in patients with chronic kidney disease. J Am Heart Assoc8: e011013, 2019PubMed
KuE, HsuRK, TuotDS, BaeSR, LipkowitzMS, SmogorzewskiMJ, .: Magnitude of the difference between clinic and ambulatory blood pressures and risk of adverse outcomes in patients with chronic kidney disease. J Am Heart Assoc8: e011013, 2019PubMed10.1161/JAHA.118.011013)| false
McManusRJ, MantJ, HaqueMS, BrayEP, BryanS, GreenfieldSM, et al..: Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: The TASMIN-SR randomized clinical trial. JAMA312: 799–808, 2014PubMed
McManusRJ, MantJ, HaqueMS, BrayEP, BryanS, GreenfieldSM, .: Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: The TASMIN-SR randomized clinical trial. JAMA312: 799–808, 2014PubMed10.1001/jama.2014.10057)| false
GuoQH, ChengYB, ZhangDY, WangY, HuangQF, ShengCS, et al..: Comparison between home and ambulatory morning blood pressure and morning hypertension in their reproducibility and associations with vascular injury. Hypertension74: 137–144, 2019PubMed
GuoQH, ChengYB, ZhangDY, WangY, HuangQF, ShengCS, .: Comparison between home and ambulatory morning blood pressure and morning hypertension in their reproducibility and associations with vascular injury. Hypertension74: 137–144, 2019PubMed10.1161/HYPERTENSIONAHA.119.12955)| false
StergiouGS, AsayamaK, ThijsL, KolliasA, NiiranenTJ, HozawaA, et al..: International Database on HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO) Investigators: Prognosis of white-coat and masked hypertension: International database of HOme blood pressure in relation to Cardiovascular Outcome. Hypertension63: 675–682, 2014PubMed
StergiouGS, AsayamaK, ThijsL, KolliasA, NiiranenTJ, HozawaA, .: International Database on HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO) Investigators: Prognosis of white-coat and masked hypertension: International database of HOme blood pressure in relation to Cardiovascular Outcome. Hypertension63: 675–682, 2014PubMed10.1161/HYPERTENSIONAHA.113.02741)| false
PierdomenicoSD, PierdomenicoAM, CoccinaF, ClementDL, De BuyzereML, De BacquerDA, et al..: Prognostic value of masked uncontrolled hypertension. Hypertension72: 862–869, 2018PubMed
PierdomenicoSD, PierdomenicoAM, CoccinaF, ClementDL, De BuyzereML, De BacquerDA, .: Prognostic value of masked uncontrolled hypertension. Hypertension72: 862–869, 2018PubMed10.1161/HYPERTENSIONAHA.118.11499)| false
KangYY, LiY, HuangQF, SongJ, ShanXL, DouY, et al..: Accuracy of home versus ambulatory blood pressure monitoring in the diagnosis of white-coat and masked hypertension. J Hypertens33: 1580–1587, 2015PubMed
KangYY, LiY, HuangQF, SongJ, ShanXL, DouY, .: Accuracy of home versus ambulatory blood pressure monitoring in the diagnosis of white-coat and masked hypertension. J Hypertens33: 1580–1587, 2015PubMed10.1097/HJH.0000000000000596)| false
ShimboD, AbdallaM, FalzonL, TownsendRR, MuntnerP: Studies comparing ambulatory blood pressure and home blood pressure on cardiovascular disease and mortality outcomes: A systematic review. J Am Soc Hypertens10: 224–234.e17, 2016PubMed
ShimboD, AbdallaM, FalzonL, TownsendRR, MuntnerP: Studies comparing ambulatory blood pressure and home blood pressure on cardiovascular disease and mortality outcomes: A systematic review. J Am Soc Hypertens10: 224–234.e17, 2016PubMed10.1016/j.jash.2015.12.013)| false
AgarwalR, AndersenMJ: Blood pressure recordings within and outside the clinic and cardiovascular events in chronic kidney disease. Am J Nephrol26: 503–510, 2006PubMed
AgarwalR, AndersenMJ: Blood pressure recordings within and outside the clinic and cardiovascular events in chronic kidney disease. Am J Nephrol26: 503–510, 2006PubMed10.1159/000097366)| false
SheppardJP, FletcherB, GillP, MartinU, RobertsN, McManusRJ: Predictors of the home-clinic blood pressure difference: A systematic review and meta-analysis. Am J Hypertens29: 614–625, 2016PubMed
SheppardJP, FletcherB, GillP, MartinU, RobertsN, McManusRJ: Predictors of the home-clinic blood pressure difference: A systematic review and meta-analysis. Am J Hypertens29: 614–625, 2016PubMed10.1093/ajh/hpv157)| false
BoothJN3rd, HubbardD, SakhujaS, YanoY, WheltonPK, WrightJTJr, et al..: Proportion of US adults recommended out-of-clinic blood pressure monitoring according to the 2017 hypertension clinical practice guidelines. hypertension74: 399–406, 2019PubMed
BoothJN3rd, HubbardD, SakhujaS, YanoY, WheltonPK, WrightJTJr, .: Proportion of US adults recommended out-of-clinic blood pressure monitoring according to the 2017 hypertension clinical practice guidelines. hypertension74: 399–406, 2019PubMed10.1161/HYPERTENSIONAHA.119.12775)| false
CohenJB, LotitoMJ, TrivediUK, DenkerMG, CohenDL, TownsendRR: Cardiovascular events and mortality in white coat hypertension: A systematic review and meta-analysis. Ann Intern Med170: 853–862, 2019PubMed
CohenJB, LotitoMJ, TrivediUK, DenkerMG, CohenDL, TownsendRR: Cardiovascular events and mortality in white coat hypertension: A systematic review and meta-analysis. Ann Intern Med170: 853–862, 2019PubMed10.7326/M19-0223)| false
ShimboD, MuntnerP: Should out-of-office monitoring be performed for detecting white coat hypertension?Ann Intern Med170: 890–892, 2019PubMed10.7326/M19-1134)| false
MuntnerP, WhittleJ, LynchAI, ColantonioLD, SimpsonLM, EinhornPT, et al..: Visit-to-visit variability of blood pressure and coronary heart disease, stroke, heart failure, and mortality: A cohort study. Ann Intern Med163: 329–338, 2015PubMed
StergiouGS, GiovasPP, GkinosCP, PatourasJD: Validation of the Microlife WatchBP Home device for self home blood pressure measurement according to the international protocol. Blood Press Monit12: 185–188, 2007PubMed
StergiouGS, GiovasPP, GkinosCP, PatourasJD: Validation of the Microlife WatchBP Home device for self home blood pressure measurement according to the international protocol. Blood Press Monit12: 185–188, 2007PubMed10.1097/MBP.0b013e3280b083ce)| false
DrawzPE, BrownR, De NicolaL, FujiiN, GabbaiFB, GassmanJ, et al..: CRIC Study Investigators: Variations in 24-hour BP profiles in cohorts of patients with kidney disease around the world: the I-DARE study. clin j am soc nephrol13: 1348–1357, 2018PubMed
DrawzPE, BrownR, De NicolaL, FujiiN, GabbaiFB, GassmanJ, .: CRIC Study Investigators: Variations in 24-hour BP profiles in cohorts of patients with kidney disease around the world: the I-DARE study. clin j am soc nephrol13: 1348–1357, 2018PubMed10.2215/CJN.13181117)| false
SallesGF, ReboldiG, FagardRH, CardosoCR, PierdomenicoSD, VerdecchiaP, et al..: ABC-H Investigators: Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: The ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension67: 693–700, 2016PubMed
SallesGF, ReboldiG, FagardRH, CardosoCR, PierdomenicoSD, VerdecchiaP, .: ABC-H Investigators: Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: The ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension67: 693–700, 2016PubMed10.1161/HYPERTENSIONAHA.115.06981)| false
HermidaRC, AyalaDE, MojónA, FernándezJR: Influence of circadian time of hypertension treatment on cardiovascular risk: Results of the MAPEC study. Chronobiol Int27: 1629–1651, 2010PubMed
HermidaRC, AyalaDE, MojónA, FernándezJR: Influence of circadian time of hypertension treatment on cardiovascular risk: Results of the MAPEC study. Chronobiol Int27: 1629–1651, 2010PubMed10.3109/07420528.2010.510230)| false
DingX, YanBP, ZhangYT, LiuJ, ZhaoN, TsangHK: Pulse transit time based continuous cuffless blood pressure estimation: A new extension and a comprehensive evaluation. Sci Rep7: 11554, 2017PubMed
DingX, YanBP, ZhangYT, LiuJ, ZhaoN, TsangHK: Pulse transit time based continuous cuffless blood pressure estimation: A new extension and a comprehensive evaluation. Sci Rep7: 11554, 2017PubMed10.1038/s41598-017-11507-3)| false
TuckerKL, SheppardJP, StevensR, BosworthHB, BoveA, BrayEP, et al..: Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis. PLoS Med14: e1002389, 2017PubMed
McManusRJ, MantJ, FranssenM, NicklessA, SchwartzC, HodgkinsonJ, et al..: TASMINH4 investigators: Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet391: 949–959, 2018PubMed
McManusRJ, MantJ, FranssenM, NicklessA, SchwartzC, HodgkinsonJ, .: TASMINH4 investigators: Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet391: 949–959, 2018PubMed10.1016/S0140-6736(18)30309-X)| false
FunderJW, CareyRM, ManteroF, MuradMH, ReinckeM, ShibataH, et al..: The management of primary aldosteronism: Case detection, diagnosis, and treatment: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab101: 1889–1916, 2016PubMed
FunderJW, CareyRM, ManteroF, MuradMH, ReinckeM, ShibataH, .: The management of primary aldosteronism: Case detection, diagnosis, and treatment: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab101: 1889–1916, 2016PubMed10.1210/jc.2015-4061)| false
MonticoneS, D’AscenzoF, MorettiC, WilliamsTA, VeglioF, GaitaF, et al..: Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: A systematic review and meta-analysis. Lancet Diabetes Endocrinol6: 41–50, 2018PubMed
CareyRM, CalhounDA, BakrisGL, BrookRD, DaughertySL, Dennison-HimmelfarbCR, et al..: American Heart Association Professional/Public Education and Publications Committee of the Council on Hypertension; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Genomic and Precision Medicine; Council on Peripheral Vascular Disease; Council on Quality of Care and Outcomes Research; and Stroke Council: Resistant hypertension: detection, evaluation, and management: A scientific statement from the American Heart Association. Hypertension72: e53–e90, 2018PubMed
CareyRM, CalhounDA, BakrisGL, BrookRD, DaughertySL, Dennison-HimmelfarbCR, .: American Heart Association Professional/Public Education and Publications Committee of the Council on Hypertension; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Genomic and Precision Medicine; Council on Peripheral Vascular Disease; Council on Quality of Care and Outcomes Research; and Stroke Council: Resistant hypertension: detection, evaluation, and management: A scientific statement from the American Heart Association. Hypertension72: e53–e90, 2018PubMed10.1161/HYP.0000000000000084)| false
GornikHL, PersuA, AdlamD, AparicioLS, AziziM, BoulangerM, et al..: Working Group ‘Hypertension and the Kidney’ of the European Society of Hypertension (ESH) and the Society for Vascular Medicine (SVM): First international consensus on the diagnosis and management of fibromuscular dysplasia. J Hypertens37: 229–252, 2019PubMed
GornikHL, PersuA, AdlamD, AparicioLS, AziziM, BoulangerM, .: Working Group ‘Hypertension and the Kidney’ of the European Society of Hypertension (ESH) and the Society for Vascular Medicine (SVM): First international consensus on the diagnosis and management of fibromuscular dysplasia. J Hypertens37: 229–252, 2019PubMed10.1097/HJH.0000000000002019)| false
MasiS, UlianaM, GesiM, TaddeiS, VirdisA: Drug-induced hypertension: Know the problem to know how to deal with it. Vascul Pharmacol115: 84–88, 2019PubMed
MasiS, UlianaM, GesiM, TaddeiS, VirdisA: Drug-induced hypertension: Know the problem to know how to deal with it. Vascul Pharmacol115: 84–88, 2019PubMed10.1016/j.vph.2019.02.002)| false
GrossmanA, MesserliFH, GrossmanE: Drug induced hypertension: An unappreciated cause of secondary hypertension. Eur J Pharmacol763[Pt A]: 15–22, 2015PubMed
GrossmanA, MesserliFH, GrossmanE: Drug induced hypertension: An unappreciated cause of secondary hypertension. Eur J Pharmacol763[Pt A]: 15–22, 2015PubMed10.1016/j.ejphar.2015.06.027)| false
OckeneIS, MillerNH; American Heart Association Task Force on Risk Reduction: Cigarette smoking, cardiovascular disease, and stroke: A statement for healthcare professionals from the American Heart Association. Circulation96: 3243–3247, 1997PubMed
OckeneIS, MillerNH; American Heart Association Task Force on Risk Reduction: Cigarette smoking, cardiovascular disease, and stroke: A statement for healthcare professionals from the American Heart Association. Circulation96: 3243–3247, 1997PubMed10.1161/01.CIR.96.9.3243)| false
LositoA, FagugliRM, ZampiI, ParenteB, de RangoP, GiordanoG, et al..: Comparison of target organ damage in renovascular and essential hypertension. Am J Hypertens9: 1062–1067, 1996PubMed
LositoA, FagugliRM, ZampiI, ParenteB, de RangoP, GiordanoG, .: Comparison of target organ damage in renovascular and essential hypertension. Am J Hypertens9: 1062–1067, 1996PubMed10.1016/0895-7061(96)00199-9)| false
TaraziRC, FrohlichED, DustanHP, GiffordRWJr, PageIH: Hypertension and high hematocrit. Another clue to renal arterial disease. Am J Cardiol18: 855–858, 1966PubMed
TaraziRC, FrohlichED, DustanHP, GiffordRWJr, PageIH: Hypertension and high hematocrit. Another clue to renal arterial disease. Am J Cardiol18: 855–858, 1966PubMed10.1016/0002-9149(66)90430-9)| false
ConnJW, KnopfRF, NesbitRM: Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am J Surg107: 159–172, 1964PubMed10.1016/0002-9610(64)90252-1)| false
LendersJW, DuhQY, EisenhoferG, Gimenez-RoqueploAP, GrebeSK, MuradMH, et al..: Endocrine Society: Pheochromocytoma and paraganglioma: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab99: 1915–1942, 2014PubMed
GiriA, HellwegeJN, KeatonJM, ParkJ, QiuC, WarrenHR, et al..: Understanding Society Scientific Group; International Consortium for Blood Pressure; Blood Pressure-International Consortium of Exome Chip Studies; Million Veteran Program: Trans-ethnic association study of blood pressure determinants in over 750,000 individuals. Nat Genet51: 51–62, 2019PubMed
GiriA, HellwegeJN, KeatonJM, ParkJ, QiuC, WarrenHR, .: Understanding Society Scientific Group; International Consortium for Blood Pressure; Blood Pressure-International Consortium of Exome Chip Studies; Million Veteran Program: Trans-ethnic association study of blood pressure determinants in over 750,000 individuals. Nat Genet51: 51–62, 2019PubMed10.1038/s41588-018-0303-9)| false
WrightJTJr, BakrisG, GreeneT, AgodoaLY, AppelLJ, CharlestonJ, et al..: African American Study of Kidney Disease and Hypertension Study Group: Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA288: 2421–2431, 2002PubMed
WrightJTJr, BakrisG, GreeneT, AgodoaLY, AppelLJ, CharlestonJ, .: African American Study of Kidney Disease and Hypertension Study Group: Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA288: 2421–2431, 2002PubMed10.1001/jama.288.19.2421)| false
GrimmRHJr, LeonAS, HunninghakeDB, LenzK, HannanP, BlackburnH: Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: A double-blind controlled trial. Ann Intern Med94: 7–11, 1981PubMed
GrimmRHJr, LeonAS, HunninghakeDB, LenzK, HannanP, BlackburnH: Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: A double-blind controlled trial. Ann Intern Med94: 7–11, 1981PubMed10.7326/0003-4819-94-1-7)| false
KeithNM, WagenerHP, BarkerNW: Some different types of essential hypertension: Their course and prognosis. Am J Med Sci268: 336–345, 1974PubMed10.1097/00000441-197412000-00004)| false
OgdenLG, HeJ, LydickE, WheltonPK: Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension35: 539–543, 2000PubMed
OgdenLG, HeJ, LydickE, WheltonPK: Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension35: 539–543, 2000PubMed10.1161/01.HYP.35.2.539)| false
Hypertension Detection and Follow-up Program Cooperative Group: Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA242: 2562–2571, 1979PubMed
Hypertension Detection and Follow-up Program Cooperative Group: Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA242: 2562–2571, 1979PubMed)| false
PickettCA, JacksonJL, HemannBA, AtwoodJE: Carotid bruits as a prognostic indicator of cardiovascular death and myocardial infarction: A meta-analysis. Lancet371: 1587–1594, 2008PubMed
PickettCA, JacksonJL, HemannBA, AtwoodJE: Carotid bruits as a prognostic indicator of cardiovascular death and myocardial infarction: A meta-analysis. Lancet371: 1587–1594, 2008PubMed10.1016/S0140-6736(08)60691-1)| false
TurnbullJM: The rational clinical examination: Is listening for abdominal bruits useful in the evaluation of hypertension?JAMA274: 1299–1301, 1995PubMed
TurnbullJM: The rational clinical examination: Is listening for abdominal bruits useful in the evaluation of hypertension?JAMA274: 1299–1301, 1995PubMed10.1001/jama.1995.03530160051033)| false
ClementDL, DebuyzereML: How to treat hypertension in patients with peripheral artery disease. Curr Hypertens Rep9: 190–195, 2007PubMed10.1007/s11906-007-0034-2)| false